Filing Details
- Accession Number:
- 0001127602-21-023999
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-18 19:32:02
- Reporting Period:
- 2021-08-17
- Accepted Time:
- 2021-08-18 19:32:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1374988 | E. Diane Wilfong | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Svp, Controller & Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-17 | 9,781 | $68.75 | 30,179 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-08-17 | 3,829 | $66.36 | 34,008 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-17 | 13,610 | $72.50 | 20,398 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2021-08-17 | 9,781 | $0.00 | 9,781 | $68.75 |
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2021-08-17 | 3,829 | $0.00 | 3,829 | $66.36 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,869 | 2029-02-06 | No | 4 | M | Direct | |
| 0 | 2027-02-10 | No | 4 | M | Direct |
Footnotes
- The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Billionaire Hedge Funds
